Vor Biopharma (VOR) Shares Outstanding (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Shares Outstanding data on file, last reported at $54.2 million in Q1 2026.

• Shares Outstanding for Q1 2026 came in at $54.2 million, up 768.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $54.2 million (up 768.0% YoY), and the FY2025 annual result was $38.7 million, up 520.64% from the prior year.
• Shares Outstanding improved to $54.2 million in Q1 2026 per VOR's latest filing, from $38.7 million in the prior quarter.
• Over five years, Shares Outstanding peaked at $67.8 million in Q3 2023 and troughed at $3.4 million in Q4 2023.
• A 5-year average of $30.3 million and a median of $37.3 million in 2022 frame the typical range for Shares Outstanding.
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding sank 94.94% in 2024, then soared 768.0% in 2026.
• A 5-year view of Shares Outstanding shows it stood at $66.0 million in 2022, then slumped by 94.86% to $3.4 million in 2023, then surged by 83.76% to $6.2 million in 2024, then surged by 520.64% to $38.7 million in 2025, then surged by 39.94% to $54.2 million in 2026.
• Business Quant data shows VOR's Shares Outstanding at $54.2 million in Q1 2026, $38.7 million in Q4 2025, and $9.0 million in Q3 2025.